Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for Premier Medical COVID-19 Test

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization for Premier Medical Laboratory Services' PCR-based SARS-CoV-2 assay.

The PMLS SARS-CoV-2 Assay is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in anterior nasal swab specimens collected using the Self Collection Kit.

Testing with the assay is limited to Greenville, South Carolina-based Premier Medical, according to the FDA.

In December 2020, Premier Medical partnered with TNG Dx to develop a rapid RNA extraction protocol for use with SARS-CoV-2 diagnostics.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.